AN2 Therapeutics, Inc., (ANTX): Price and Financial Metrics

AN2 Therapeutics, Inc., (ANTX): $1.30

0.24 (+22.64%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ANTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#112 of 332

in industry

ANTX Price/Volume Stats

Current price $1.30 52-week high $22.22
Prev. close $1.06 52-week low $0.87
Day low $1.07 Volume 5,552,700
Day high $1.33 Avg. volume 423,229
50-day MA $1.06 Dividend yield N/A
200-day MA $2.34 Market Cap 38.84M

ANTX Stock Price Chart Interactive Chart >


AN2 Therapeutics, Inc., (ANTX) Company Bio


AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.


ANTX Latest News Stream


Event/Time News Detail
Loading, please wait...

ANTX Latest Social Stream


Loading social stream, please wait...

View Full ANTX Social Stream

ANTX Price Returns

1-mo 20.37%
3-mo 18.18%
6-mo -35.64%
1-year -91.90%
3-year N/A
5-year N/A
YTD -93.66%
2023 115.01%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!